Latest hormone therapy Stories
FLINT, Mich., March 1, 2012 /PRNewswire/ -- In an effort to put Chicago on the map as the healthiest city in the United States, Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy offering bioidentical hormone therapy, and Ageology anti-aging physician network have formed a strategic alliance. The two companies focus on delivering holistic preventative care to men and women looking to fight chronic diseases with nutrition, fitness and bioidentical...
CHICAGO, Feb. 28, 2012 /PRNewswire/ -- Put down the pizza, pick up the dumbbell. Baby Boomers, Echo-boomers (born to baby-boomers), Xers and Generation Y have one thing in common: they want to stay young and be healthy. Ageology Likes This! Ageology, an anti-aging social network, launched in an effort to help bridge the health disconnect, the gap between public perception and the scientific facts about health, nutrition, fitness and bioidentical hormone therapy. Debuting in the...
EMERYVILLE, Calif., Dec. 8, 2011 /PRNewswire/ -- Bionovo, Inc. (NASDAQ: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the publication of a study on the effects of two botanically-derived, tissue selective estrogen receptor modulators for the treatment of postmenopausal obesity in the Journal of the Public Library of Science One. (Logo:...
A first-of-its kind study led by Xiao-Cheng Wu, MD, MPH, Associate Professor of Public Health at LSU Health Sciences Center New Orleans, reports that a significant number of women are not receiving guideline-recommended treatment for breast cancer and what factors contribute. The research is published online in the Journal of Clinical Oncology December 5, 2011 Early Release section. The research team, which also included Vivien Chen, PhD, Professor and Director of the Louisiana Tumor...
Fashion stylist Lisa Rogers gives her tips on staying cool while you're hot during menopause TORONTO, Dec. 5, 2011 /PRNewswire/ - Hot flashes are a tough part of menopause for many women. However, women dressing for the holiday season can make smart fashion choices that look great and help them keep their cool. Today, Dr. Vivien Brown and Canadian fashion stylist Lisa Rogers team up to show women that whether it's choosing a great outfit or treatment options, managing...
(Ivanhoe Newswire) – Men with locally advanced or high-risk prostate cancer who receive radiation and hormone therapy live longer and are less likely to die from their disease, according to this study. "The study shows combining radiation and hormone therapy improves overall survival by 23 percent and disease-specific survival by 43 percent, compared with treating with hormone therapy alone," Principal investigator Padraig Warde, deputy head, PMH radiation medicine program, was quoted as...
Among men with high-risk prostate cancer Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at the Princess Margaret Hospital (PMH) Cancer Program, University Health Network. The findings are published online today in The Lancet (doi: 10.1016/S0140-6736(11)61095-7). Principal investigator Padraig Warde, deputy head, PMH...
Women still have hot flushes and night sweats years after the menopause finds a new study published today in BJOG: An International Journal of Obstetrics and Gynaecology. Hot flushes and night sweats (HF/NS) are the main physical signs of the menopause, however their prevalence, frequency, severity and duration vary considerably. The average age of the menopause in US and European women is 50-51 years and it is generally assumed that HF/NS last between 2 to 5 years. This study looked...
Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast tenderness, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has shown. One reason for this may be that their breasts are becoming more dense. The new onset tenderness was much more pronounced after initiation of estrogen and progestin therapy than in women getting estrogen...
Adding hormone therapy to radiation therapy has been proven in randomized clinical trials to improve overall survival for men with intermediate- and high-risk prostate cancer. However, adding hormone therapy may reduce overall survival in men with pre-existing heart conditions, even if they have high-risk prostate cancer according to a new study just published online in advance of print in the International Journal of Radiation Oncology"¢Biology"¢Physics, the official scientific journal of...
